Amphastar P
AMPHAmphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures and sells inhalation and intranasal products.One of its products is naloxone, an injectable generic drug that treats opioid overdose, and th …
© Wikipedia /
Creative Commons CC-BY-SA 3.0
more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at Amphastar P
Subscribe RSS| Date | Type | Ø-Price | Volume |
|---|---|---|---|
| 8/11/2026 | Sell | $20.3 | $161,852 |
| 8/7/2026 | Sell | $22.5 | $183,886 |
| 12/17/2025 | Sell | $26.2 | $256,379 |
| 12/12/2025 | Sell | $25.9 | $62,888 |
| 12/11/2025 | Sell | $25.7 | $44,620 |
| 11/25/2025 | Sell | $27.1 | $113,253 |
| 11/13/2025 | Sell | $26.5 | $441,837 |
| 11/3/2025 | Sell | $25.3 | $12,633 |
| 10/1/2025 | Sell | $27.2 | $13,602 |
| 9/2/2025 | Sell | $31.0 | $15,492 |
| 8/1/2025 | Sell | $20.8 | $10,416 |
| 7/2/2025 | Sell | $23.5 | $11,734 |
| 6/2/2025 | Sell | $25.7 | $12,835 |
| 5/1/2025 | Sell | $24.1 | $12,041 |
| 4/1/2025 | Sell | $28.4 | $14,190 |
| 3/6/2025 | Sell | $28.0 | $27,986 |
| 3/4/2025 | Sell | $27.5 | $116,515 |
| 12/13/2024 | Sell | $45.2 | $361,840 |
| 12/12/2024 | Sell | $44.4 | $310,975 |
| 12/9/2024 | Sell | $43.8 | $437,702 |
| 11/12/2024 | Sell | $48.8 | $243,986 |
| 11/12/2024 | Sell | $48.9 | $336,930 |
| 11/6/2024 | Sell | $52.0 | $386,523 |
| 11/6/2024 | Sell | $52.0 | $271,389 |
| 9/13/2024 | Sell | $48.3 | $144,785 |
| 9/5/2024 | Sell | $46.5 | $139,417 |
| 8/26/2024 | Sell | $48.4 | $193,400 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)